{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:23:37Z","timestamp":1784550217555,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T00:00:00Z","timestamp":1404950400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12032-014-0109-2","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T15:57:09Z","timestamp":1404921429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications"],"prefix":"10.1007","volume":"31","author":[{"given":"Joanna","family":"Przybyl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kosela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomir","family":"Falkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Switaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Lugowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szumera-Cieckiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Ptaszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Grygalewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Chechlinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pienkowska-Grela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Debiec-Rychter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz A.","family":"Siedlecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,10]]},"reference":[{"key":"109_CR1","volume-title":"WHO classification of tumours of soft tissue and bone","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.","edition":"4"},{"issue":"5","key":"109_CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1634\/theoncologist.11-5-503","volume":"11","author":"M Bernstein","year":"2006","unstructured":"Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H. Ewing\u2019s sarcoma family of tumors: current management. Oncologist. 2006;11(5):503\u201319.","journal-title":"Oncologist"},{"issue":"6","key":"109_CR3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/jjco\/hyr033","volume":"41","author":"JA Lee","year":"2011","unstructured":"Lee JA, Kim DH, Cho J, Lim JS, Koh JS, Yoo JY, Kim MS, Kong CB, Song WS, Cho WH, Lee SY, Jeon DG. Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience. Jpn J Clin Oncol. 2011;41(6):776\u201382.","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"109_CR4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1200\/JCO.1997.15.2.583","volume":"15","author":"DC West","year":"1997","unstructured":"West DC, Grier HE, Swallow MM, Demetri GD, Granowetter L, Sklar J. Detection of circulating tumor cells in patients with Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumor. J Clin Oncol. 1997;15(2):583\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"109_CR5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/cncr.20059","volume":"100","author":"S Avigad","year":"2004","unstructured":"Avigad S, Cohen IJ, Zilberstein J, Liberzon E, Goshen Y, Ash S, Meller I, Kollender Y, Issakov J, Zaizov R, Yaniv I. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer. 2004;100(5):1053\u20138.","journal-title":"Cancer"},{"issue":"32","key":"109_CR6","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1038\/onc.2010.205","volume":"29","author":"EC Toomey","year":"2010","unstructured":"Toomey EC, Schiffman JD, Lessnick SL. Recent advances in the molecular pathogenesis of Ewing\u2019s sarcoma. Oncogene. 2010;29(32):4504\u201316.","journal-title":"Oncogene"},{"issue":"9","key":"109_CR7","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1158\/1078-0432.CCR-10-3069","volume":"17","author":"S Ash","year":"2011","unstructured":"Ash S, Luria D, Cohen IJ, Goshen Y, Toledano H, Issakov J, Yaniv I, Avigad S. Excellent prognosis in a subset of patients with Ewing sarcoma identified at diagnosis by CD56 using flow cytometry. Clin Cancer Res. 2011;17(9):2900\u20137.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"109_CR8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ajpath.2011.05.034","volume":"179","author":"T Fujiwara","year":"2011","unstructured":"Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, Yamada H, Okada S, Watari K, Ono M, Kuwano M, Kamura S, Iida K, Okada Y, Koga M, Iwamoto Y. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. Am J Pathol. 2011;179(3):1157\u201370.","journal-title":"Am J Pathol"},{"issue":"2","key":"109_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/path.2869","volume":"225","author":"R Taylor","year":"2011","unstructured":"Taylor R, Knowles HJ, Athanasou NA. Ewing sarcoma cells express RANKL and support osteoclastogenesis. J Pathol. 2011;225(2):195\u2013202.","journal-title":"J Pathol."},{"issue":"4","key":"109_CR10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4103\/0019-5413.69304","volume":"44","author":"SS Desai","year":"2010","unstructured":"Desai SS, Jambhekar NA. Pathology of Ewing\u2019s sarcoma\/PNET: current opinion and emerging concepts. Indian J Orthop. 2010;44(4):363\u20138. doi: 10.4103\/0019-5413.69304 .","journal-title":"Indian J Orthop."},{"issue":"11","key":"109_CR11","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/sj.bjc.6603774","volume":"96","author":"YS Lau","year":"2007","unstructured":"Lau YS, Adamopoulos IE, Sabokbar A, Giele H, Gibbons CL, Athanasou NA. Cellular and humoral mechanisms of osteoclast formation in Ewing\u2019s sarcoma. Br J Cancer. 2007;96(11):1716\u201322.","journal-title":"Br J Cancer"},{"issue":"5","key":"109_CR12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"2","key":"109_CR13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-4608(88)90285-3","volume":"32","author":"C Turc-Carel","year":"1988","unstructured":"Turc-Carel C, Aurias A, Mugneret F, Lizard S, Sidaner I, Volk C, Thiery JP, Olschwang S, Philip I, Berger MP, Philip T, Lenoir GM, Mazabraud A. Chromosomes in Ewing\u2019s sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet. 1988;32(2):229\u201338.","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"109_CR14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJM199408043310503","volume":"331","author":"O Delattre","year":"1994","unstructured":"Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G. The Ewing family of tumors\u2014a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 1994;331(5):294\u20139.","journal-title":"N Engl J Med"},{"issue":"12","key":"109_CR15","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1002\/j.1460-2075.1993.tb06137.x","volume":"12","author":"J Zucman","year":"1993","unstructured":"Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 1993;12(12):4481\u20137.","journal-title":"EMBO J"},{"issue":"6391","key":"109_CR16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/359162a0","volume":"359","author":"O Delattre","year":"1992","unstructured":"Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359(6391):162\u20135.","journal-title":"Nature"},{"issue":"12","key":"109_CR17","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1128\/MCB.13.12.7393","volume":"13","author":"WA May","year":"1993","unstructured":"May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT. The Ewing\u2019s sarcoma EWS\/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol. 1993;13(12):7393\u20138.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"109_CR18","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1128\/MCB.14.5.3230","volume":"14","author":"RA Bailly","year":"1994","unstructured":"Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J. DNA-binding and transcriptional activation properties of the EWS\u2013FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol. 1994;14(5):3230\u201341.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"109_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13402-013-0126-8","volume":"36","author":"B Pat\u00f3cs","year":"2013","unstructured":"Pat\u00f3cs B, N\u00e9meth K, Garami M, Arat\u00f3 G, Kovalszky I, Szendr\u0151i M, Fekete G. Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors. Cell Oncol Dordr. 2013;36(3):191\u2013200.","journal-title":"Cell Oncol Dordr."},{"issue":"7","key":"109_CR20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5858\/2005-129-866-PFTEOS","volume":"129","author":"DF Carpentieri","year":"2005","unstructured":"Carpentieri DF, Qualman SJ, Bowen J, Krausz T, Marchevsky A, Dickman PS, Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from pediatric and adult patients with osseous and extraosseous ewing sarcoma family of tumors, including peripheral primitive neuroectodermal tumor and ewing sarcoma. Arch Pathol Lab Med. 2005;129(7):866\u201373.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"109_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/modpathol.3800486","volume":"19","author":"RS Bridge","year":"2006","unstructured":"Bridge RS, Rajaram V, Dehner LP, Pfeifer JD, Perry A. Molecular diagnosis of Ewing sarcoma\/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol. 2006;19(1):1\u20138.","journal-title":"Mod Pathol"},{"issue":"4","key":"109_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2559.2006.02318.x","volume":"48","author":"DC Mangham","year":"2006","unstructured":"Mangham DC, Williams A, McMullan DJ, McClure J, Sumathi VP, Grimer RJ, Davies AM. Ewing\u2019s sarcoma of bone: the detection of specific transcripts in a large, consecutive series of formalin-fixed, decalcified, paraffin-embedded tissue samples using the reverse transcriptase-polymerase chain reaction. Histopathology. 2006;48(4):363\u201376.","journal-title":"Histopathology"},{"issue":"12","key":"109_CR23","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1200\/JCO.2009.23.3585","volume":"28","author":"MC Deley Le","year":"2010","unstructured":"Le Deley MC, Delattre O, Schaefer KL, Burchill SA, Koehler G, Hogendoorn PC, Lion T, Poremba C, Marandet J, Ballet S, Pierron G, Brownhill SC, Nesslb\u00f6ck M, Ranft A, Dirksen U, Oberlin O, Lewis IJ, Craft AW, J\u00fcrgens H, Kovar H. Impact of EWS\u2013ETS fusion type on disease progression in Ewing\u2019s sarcoma\/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol. 2010;28(12):1982\u20138. doi: 10.1200\/JCO.2009.23.3585 .","journal-title":"J Clin Oncol"},{"issue":"12","key":"109_CR24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1200\/JCO.2009.24.5845","volume":"28","author":"JA Doorninck van","year":"2010","unstructured":"van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children\u2019s Oncology Group. J Clin Oncol. 2010;28(12):1989\u201394. doi: 10.1200\/JCO.2009.24.5845 .","journal-title":"J Clin Oncol"},{"issue":"12","key":"109_CR25","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1200\/JCO.2009.27.2161","volume":"28","author":"FG Barr","year":"2010","unstructured":"Barr FG, Meyer W. Role of fusion subtype in Ewing sarcoma. J Clin Oncol. 2010;28(12):1973\u20134. doi: 10.1200\/JCO.2009.27.2161 .","journal-title":"J Clin Oncol"},{"issue":"8","key":"109_CR26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/01.pas.0000167056.13614.62","volume":"29","author":"AL Folpe","year":"2005","unstructured":"Folpe AL, Goldblum JR, Rubin BP, Shehata BM, Liu W, Dei Tos AP, Weiss SW. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol. 2005;29(8):1025\u201333.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"109_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00822028","volume":"414","author":"S Daugaard","year":"1989","unstructured":"Daugaard S, Kamby C, Sunde LM, Myhre-Jensen O, Schi\u00f8dt T. Ewing\u2019s sarcoma. A retrospective study of histological and immunohistochemical factors and their relation to prognosis. Virchows Arch A Pathol Anat Histopathol. 1989;414(3):243\u201351.","journal-title":"Virchows Arch A Pathol Anat Histopathol."},{"issue":"5","key":"109_CR28","first-page":"847","volume":"135","author":"S Lizard-Nacol","year":"1989","unstructured":"Lizard-Nacol S, Lizard G, Justrabo E, Turc-Carel C. Immunologic characterization of Ewing\u2019s sarcoma using mesenchymal and neural markers. Am J Pathol. 1989;135(5):847\u201355.","journal-title":"Am J Pathol"},{"issue":"8","key":"109_CR29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","volume":"10","author":"E Crowley","year":"2013","unstructured":"Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10(8):472\u201384. doi: 10.1038\/nrclinonc.2013.110 .","journal-title":"Nat Rev Clin Oncol."},{"key":"109_CR30","doi-asserted-by":"crossref","unstructured":"Krebs MG, Metcalf RL, Carter L, Brady G, Blackhall FH, Dive C. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol. 2014; doi: 10.1038\/nrclinonc.2013.253 .","DOI":"10.1038\/nrclinonc.2013.253"},{"issue":"1","key":"109_CR31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/bjc.1995.283","volume":"72","author":"M Peter","year":"1995","unstructured":"Peter M, Magdelenat H, Michon J, Melot T, Oberlin O, Zucker JM, Thomas G, Delattre O. Sensitive detection of occult Ewing\u2019s cells by the reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995;72(1):96\u2013100.","journal-title":"Br J Cancer"},{"issue":"2","key":"109_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ijc.2910640211","volume":"64","author":"C Pfleiderer","year":"1995","unstructured":"Pfleiderer C, Zoubek A, Gruber B, Kronberger M, Ambros PF, Lion T, Fink FM, Gadner H, Kovar H. Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR. Int J Cancer. 1995;64(2):135\u20139.","journal-title":"Int J Cancer"},{"issue":"5","key":"109_CR33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jnci\/87.5.385","volume":"87","author":"JA Toretsky","year":"1995","unstructured":"Toretsky JA, Neckers L, Wexler LH. Detection of (11;22)(q24;q12) translocation-bearing cells in peripheral blood progenitor cells of patients with Ewing\u2019s sarcoma family of tumors. J Natl Cancer Inst. 1995;87(5):385\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"109_CR34","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1200\/JCO.1998.16.5.1707","volume":"16","author":"C Fagnou","year":"1998","unstructured":"Fagnou C, Michon J, Peter M, Bernoux A, Oberlin O, Zucker JM, Magdelenat H, Delattre O. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing\u2019s tumor. Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique. J Clin Oncol. 1998;16(5):1707\u201311.","journal-title":"J Clin Oncol"},{"issue":"1","key":"109_CR35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JCO.2003.03.006","volume":"21","author":"G Schleiermacher","year":"2003","unstructured":"Schleiermacher G, Peter M, Oberlin O, Philip T, Rubie H, Mechinaud F, Sommelet-Olive D, Landman-Parker J, Bours D, Michon J, Delattre O. Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor. J Clin Oncol. 2003;21(1):85\u201391.","journal-title":"J Clin Oncol"},{"key":"109_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2407-3-3","volume":"3","author":"SE DePrimo","year":"2003","unstructured":"DePrimo SE, Wong LM, Khatry DB, Nicholas SL, Manning WC, Smolich BD, O\u2019Farrell AM, Cherrington JM. Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification. BMC Cancer. 2003;3:3.","journal-title":"BMC Cancer"},{"issue":"18","key":"109_CR37","first-page":"6069","volume":"63","author":"NC Twine","year":"2003","unstructured":"Twine NC, Stover JA, Marshall B, Dukart G, Hidalgo M, Stadler W, Logan T, Dutcher J, Hudes G, Dorner AJ, Slonim DK, Trepicchio WL, Burczynski ME. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res. 2003;63(18):6069\u201375.","journal-title":"Cancer Res"},{"issue":"3","key":"109_CR38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.1181.11.3","volume":"11","author":"ME Burczynski","year":"2005","unstructured":"Burczynski ME, Twine NC, Dukart G, Marshall B, Hidalgo M, Stadler WM, Logan T, Dutcher J, Hudes G, Trepicchio WL, Strahs A, Immermann F, Slonim DK, Dorner AJ. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clin Cancer Res. 2005;11(3):1181\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"109_CR39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/030089160809400115","volume":"94","author":"Z Csontos","year":"2008","unstructured":"Csontos Z, N\u00e1dasi E, Csejtey A, Ill\u00e9nyi L, Kassai M, Luk\u00e1cs L, Kelemen D, Kvarda A, Z\u00f3lyomi A, Horv\u00e1th OP, Ember I. Oncogene and tumor suppressor gene expression changes in the peripheral blood leukocytes of patients with colorectal cancer. Tumori. 2008;94(1):79\u201382.","journal-title":"Tumori."},{"issue":"24","key":"109_CR40","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1158\/0008-5472.CAN-09-1378","volume":"69","author":"MK Showe","year":"2009","unstructured":"Showe MK, Vachani A, Kossenkov AV, Yousef M, Nichols C, Nikonova EV, Chang C, Kucharczuk J, Tran B, Wakeam E, Yie TA, Speicher D, Rom WN, Albelda S, Showe LC. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res. 2009;69(24):9202\u201310.","journal-title":"Cancer Res"},{"issue":"12","key":"109_CR41","doi-asserted-by":"crossref","first-page":"e50221","DOI":"10.1371\/journal.pone.0050221","volume":"7","author":"B Wolf","year":"2012","unstructured":"Wolf B, Schwarzer A, C\u00f4t\u00e9 AL, Hampton TH, Schwaab T, Huarte E, Tomlinson CR, Gui J, Fisher JL, Fadul CE, Hamilton JW, Ernstoff MS. Gene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-\u03b1 and dendritic cell vaccine. PLoS ONE. 2012;7(12):e50221. doi: 10.1371\/journal.pone.0050221 .","journal-title":"PLoS ONE"},{"key":"109_CR42","doi-asserted-by":"crossref","unstructured":"Palma P, Cuadros M, Conde-Mu\u00ed\u00f1o R, Olmedo C, Cano C, Segura-Jim\u00e9nez I, Blanco A, Bueno P, Ferr\u00f3n JA, Medina P. Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer. PLoS One. 2013;8(9):e74034. doi: 10.1371\/journal.pone.0074034 . eCollection 2013.","DOI":"10.1371\/journal.pone.0074034"},{"issue":"55","key":"109_CR43","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1038\/sj.onc.1208060","volume":"23","author":"A Ohali","year":"2004","unstructured":"Ohali A, Avigad S, Zaizov R, Ophir R, Horn-Saban S, Cohen IJ, Meller I, Kollender Y, Issakov J, Yaniv I. Prediction of high risk Ewing\u2019s sarcoma by gene expression profiling. Oncogene. 2004;23(55):8997\u20139006.","journal-title":"Oncogene"},{"issue":"23","key":"109_CR44","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1158\/1078-0432.CCR-07-1417","volume":"13","author":"IY Cheung","year":"2007","unstructured":"Cheung IY, Feng Y, Danis K, Shukla N, Meyers P, Ladanyi M, Cheung NK. Novel markers of subclinical disease for Ewing family tumors from gene expression profiling. Clin Cancer Res. 2007;13(23):6978\u201383.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"109_CR45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejca.2008.01.020","volume":"44","author":"KL Schaefer","year":"2008","unstructured":"Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Juergens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, Gosheger G, Schneider DT, Bury C, Diallo-Danebrock R, Ottaviano L, Gabbert HE, Poremba C. Microarray analysis of Ewing\u2019s sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer. 2008;44(5):699\u2013709. doi: 10.1016\/j.ejca.2008.01.020 .","journal-title":"Eur J Cancer"},{"issue":"10","key":"109_CR46","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/onc.2011.317","volume":"31","author":"C Mackintosh","year":"2012","unstructured":"Mackintosh C, Ord\u00f3\u00f1ez JL, Garc\u00eda-Dom\u00ednguez DJ, Sevillano V, Llombart-Bosch A, Szuhai K, Scotlandi K, Alberghini M, Sciot R, Sinnaeve F, Hogendoorn PC, Picci P, Knuutila S, Dirksen U, Debiec-Rychter M, Schaefer KL, de \u00c1lava E. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene. 2012;31(10):1287\u201398. doi: 10.1038\/onc.2011.317 .","journal-title":"Oncogene"},{"key":"109_CR47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fonc.2012.00054","volume":"2","author":"H Kovar","year":"2012","unstructured":"Kovar H, Alonso J, Aman P, Aryee DN, Ban J, Burchill SA, Burdach S, De Alava E, Delattre O, Dirksen U, Fourtouna A, Fulda S, Helman LJ, Herrero-Martin D, Hogendoorn PC, Kontny U, Lawlor ER, Lessnick SL, Llombart-Bosch A, Metzler M, Moriggl R, Niedan S, Potratz J, Redini F, Richter GH, Riedmann LT, Rossig C, Sch\u00e4fer BW, Schwentner R, Scotlandi K, Sorensen PH, Staege MS, Tirode F, Toretsky J, Ventura S, Eggert A, Ladenstein R. The first European interdisciplinary Ewing sarcoma research summit. Front Oncol. 2012;2:54. doi: 10.3389\/fonc.2012.00054 .","journal-title":"Front Oncol."},{"key":"109_CR48","unstructured":"Rutkowski P, Mazurkiewicz T, Krzakowski M, Ptaszy\u0144ski K, Klepacka T, Grzesiakowska U, Falkowski S, \u015awitaj T, Nowecki Z, Morysi\u0144ski T, Spindel J, Chmielik E, Dragan S, Nazar J, Kotrych D, Skowro\u0144ski J, Szumera-Cie\u0107kiewicz A, Szafra\u0144ski A, Szumi\u0142o J, Karpik M, Balcerkiewicz K, Mazuryk R, Jarosz B, Rych\u0142owska-Pruszy\u0144ska M, Rzeszutko M, Nowakowski A, Ry\u015b J, Olszewski WT, Wo\u017aniak W, on behalf of Polish Registry of Bone Tumors. Recommendations for diagnostics and therapy of adult patients with malignant primary bone tumors. Onkologia w Praktyce Klinicznej 2010, tom 6, no 6, 355\u2013369."},{"key":"109_CR49","doi-asserted-by":"crossref","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):research0034.1\u2013research0034.11.","DOI":"10.1186\/gb-2002-3-7-research0034"},{"issue":"15","key":"109_CR50","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen CL, Jensen JL, \u00d8rntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15):5245\u201350.","journal-title":"Cancer Res"},{"issue":"4","key":"109_CR51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"109_CR52","unstructured":"World Health Organization. Nutritional Anaemias: Report of a WHO Scientific Group. WHO Technical Reports Series 405. Geneva, Switzerland: World Health Organization, 1968."},{"issue":"7","key":"109_CR53","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/0008-5472.CAN-06-3259","volume":"67","author":"HG Kang","year":"2007","unstructured":"Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, Ng T, Reynolds CP, Triche TJ, Sorensen PH. E-cadherin cell\u2013cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 2007;67(7):3094\u2013105.","journal-title":"Cancer Res"},{"issue":"5","key":"109_CR54","doi-asserted-by":"crossref","first-page":"a002279","DOI":"10.1101\/cshperspect.a002279","volume":"2","author":"H Wang","year":"2010","unstructured":"Wang H, Kadlecek TA, Au-Yeung BB, Goodfellow HE, Hsu LY, Freedman TS, Weiss A. ZAP-70: an essential kinase in T-cell signaling. Cold Spring Harb Perspect Biol. 2010;2(5):a002279. doi: 10.1101\/cshperspect.a002279 .","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"51","key":"109_CR55","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"TD Gilmore","year":"2006","unstructured":"Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25(51):6680\u20134.","journal-title":"Oncogene"},{"key":"109_CR56","doi-asserted-by":"crossref","unstructured":"Gales D, Clark C, Manne U, Samuel T. The chemokine CXCL8 in carcinogenesis and drug response. ISRN Oncol. 2013;2013:859154. eCollection 2013.","DOI":"10.1155\/2013\/859154"},{"key":"109_CR57","first-page":"168712","volume":"2011","author":"S Savola","year":"2011","unstructured":"Savola S, Klami A, Myllykangas S, Manara C, Scotlandi K, Picci P, Knuutila S, Vakkila J. High expression of complement component 5 (C5) at tumor site associates with superior survival in Ewing\u2019s sarcoma family of tumour patients. ISRN Oncol. 2011;2011:168712. doi: 10.5402\/2011\/168712 .","journal-title":"ISRN Oncol."},{"issue":"Suppl 1","key":"109_CR58","doi-asserted-by":"crossref","first-page":"i109","DOI":"10.1136\/ard.59.suppl_1.i109","volume":"59","author":"JC Morris","year":"2000","unstructured":"Morris JC, Waldmann TA. Advances in interleukin 2 receptor targeted treatment. Ann Rheum Dis. 2000;59(Suppl 1):i109\u201314.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"109_CR59","first-page":"329","volume":"5","author":"I Kuss","year":"1999","unstructured":"Kuss I, Saito T, Johnson JT, Whiteside TL. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res. 1999;5(2):329\u201334.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"109_CR60","first-page":"57","volume":"29","author":"L Pignataro","year":"2007","unstructured":"Pignataro L, Pagani D, Brando B, Sambataro G, Scarpati B, Corsi MM. Down-regulation of zeta chain and zeta-associated protein 70 (Zap 70) expression in circulating T lymphocytes in laryngeal squamous cell carcinoma. Anal Quant Cytol Histol. 2007;29(1):57\u201362.","journal-title":"Anal Quant Cytol Histol"},{"issue":"1","key":"109_CR61","first-page":"173","volume":"21","author":"L Ciszak","year":"2009","unstructured":"Ciszak L, Kosmaczewska A, Werynska B, Szteblich A, Jankowska R, Frydecka I. Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer. Oncol Rep. 2009;21(1):173\u201384.","journal-title":"Oncol Rep"},{"issue":"3 Suppl","key":"109_CR62","first-page":"947s","volume":"7","author":"G Dworacki","year":"2001","unstructured":"Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL. Decreased zeta chain expression and apoptosis in CD3\u00a0+\u00a0peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res. 2001;7(3 Suppl):947s\u201357s.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"109_CR63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4049\/jimmunol.163.1.50","volume":"163","author":"D Penna","year":"1999","unstructured":"Penna D, M\u00fcller S, Martinon F, Demotz S, Iwashima M, Valitutti S. Degradation of ZAP-70 following antigenic stimulation in human T lymphocytes: role of calpain proteolytic pathway. J Immunol. 1999;163(1):50\u20136.","journal-title":"J Immunol."},{"issue":"5","key":"109_CR64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4161\/cbt.2.5.545","volume":"2","author":"H Zhang","year":"2003","unstructured":"Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL. Tumor expression of 4-1BB ligand sustains tumor lytic T cells. Cancer Biol Ther. 2003;2(5):579\u201386.","journal-title":"Cancer Biol Ther"},{"key":"109_CR65","doi-asserted-by":"crossref","unstructured":"Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, Widmayer P, Gruissem W, Zimmermann P. Genevestigator V3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinform. 2008;2008, Article ID 420747. doi: 10.1155\/2008\/420747 .","DOI":"10.1155\/2008\/420747"},{"issue":"6759","key":"109_CR66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999;402(6759):304\u20139.","journal-title":"Nature"},{"issue":"12","key":"109_CR67","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-02-0474","volume":"104","author":"S Colucci","year":"2004","unstructured":"Colucci S, Brunetti G, Rizzi R, Zonno A, Mori G, Colaianni G, Del Prete D, Faccio R, Liso A, Capalbo S, Liso V, Zallone A, Grano M. T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG\/TRAIL interaction. Blood. 2004;104(12):3722\u201330.","journal-title":"Blood"},{"issue":"1","key":"109_CR68","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar2616","volume":"11","author":"R Lari","year":"2009","unstructured":"Lari R, Kitchener PD, Hamilton JA. The proliferative human monocyte subpopulation contains osteoclast precursors. Arthritis Res Ther. 2009;11(1):R23.","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"109_CR69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","volume":"267","author":"A Sica","year":"2008","unstructured":"Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 2008;267(2):204\u201315.","journal-title":"Cancer Lett"},{"issue":"6","key":"109_CR70","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI117979","volume":"95","author":"G Mbalaviele","year":"1995","unstructured":"Mbalaviele G, Chen H, Boyce BF, Mundy GR, Yoneda T. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Invest. 1995;95(6):2757\u201365.","journal-title":"J Clin Invest."},{"issue":"12","key":"109_CR71","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1359\/JBMR.050809","volume":"20","author":"CS Shin","year":"2005","unstructured":"Shin CS, Her SJ, Kim JA, Kim DH, Kim SW, Kim SY, Kim HS, Park KH, Kim JG, Kitazawa R, Cheng SL, Civitelli R. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell\u2013cell adhesion. J Bone Miner Res. 2005;20(12):2200\u201312.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"109_CR72","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1097\/CCM.0b013e3181a001ae","volume":"37","author":"ED Crouser","year":"2009","unstructured":"Crouser ED, Shao G, Julian MW, Macre JE, Shadel GS, Tridandapani S, Huang Q, Wewers MD. Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit Care Med. 2009;37(6):2000\u20139.","journal-title":"Crit Care Med"},{"issue":"10","key":"109_CR73","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1023\/A:1012527006566","volume":"12","author":"W Ruka","year":"2001","unstructured":"Ruka W, Rutkowski P, Kaminska J, Rysinska A, Steffen J. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. Ann Oncol. 2001;12(10):1423\u201332.","journal-title":"Ann Oncol"},{"issue":"4","key":"109_CR74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4161\/cam.20855","volume":"6","author":"F P\u00e9glion","year":"2012","unstructured":"P\u00e9glion F, Etienne-Manneville S. N-cadherin expression level as a critical indicator of invasion in non-epithelial tumors. Cell Adh Migr. 2012;6(4):327\u201332.","journal-title":"Cell Adh Migr."}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0109-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0109-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0109-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T03:21:43Z","timestamp":1689391303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0109-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,10]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["109"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0109-2","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,10]]},"article-number":"109"}}